InvestorsHub Logo

misiu143

05/11/16 4:27 PM

#2130 RE: TheBioTechG #2129

This is I believe for intravenous injection ( IV ) not IM.

Inoviorulez

05/11/16 4:29 PM

#2131 RE: TheBioTechG #2129

Not only that patients have to go to the hospital twice a month for an IV. Therefore ibalizumab won't be as competitive as PRO 140